-
Monma Y, Niu K, Iwasaki K, Tomita N, Nakaya N, Hozawa A, Kuriyama S, Takayama S, Seki T, Takeda T, Yaegashi N, Ebihara S, Arai H, Nagatomi R, Tsuji I.
FORBES: Chinese Medicine Infiltrates Scientific Publishing
-
Merck announced today that the HPS2-THRIVE ( H eart P rotection S tudy 2- T reatment of H DL to R educe the I ncidence of V ascular E vents) study did not meet its primary endpoint.
FORBES: HPS2-THRIVE: No Benefit, Signal Of Harm For Niacin Therapy
-
"If I were a plan participant and I was planning to take a lump sum, I would pick up the phone and call H-R and ask about the plan funding status, " says Andrew Wozniak, an actuary at BNY Mellon Asset Management, which manages investments for dozens of large company pension plans.
FORBES: Companies Press Congress For Pension Relief
-
Liberals think they smell more than a little H-Y-P-O-C-R-I-S-Y.
FORBES: In Defense of Arizona's Medicaid Rationing
-
Can you spell h-y-p-o-c-r-i-t-e?
FORBES: Pork Holding Up Senate Sandy Relief Bill Funneled Into The Troughs Of GOP Deficit Hawks? You Betcha.